0000930413-12-001600.txt : 20120316 0000930413-12-001600.hdr.sgml : 20120316 20120316152908 ACCESSION NUMBER: 0000930413-12-001600 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120315 FILED AS OF DATE: 20120316 DATE AS OF CHANGE: 20120316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Richard A CENTRAL INDEX KEY: 0001490283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 12697538 MAIL ADDRESS: STREET 1: C/O ENZON PHARMACEUITCALS, INC. STREET 2: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c68946_form4.xml OWNERSHIP DOCUMENT X0304 4 2012-03-15 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001490283 Young Richard A C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 1 0 0 0 Common Stock 2012-03-15 4 S 0 2000 6.9211 D 19562 D Represents the sale of 2,000 shares in two separate transactions, ranging from $6.92 to $6.9212 per share, resulting in a weighted average sale price per share of $6.9211. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. /s/ Andrew Rackear, Attorney-in-Fact 2012-03-16